Correlation Between Pfizer and Bausch

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Bausch at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Bausch into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Bausch Health Companies, you can compare the effects of market volatilities on Pfizer and Bausch and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Bausch. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Bausch.

Diversification Opportunities for Pfizer and Bausch

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and Bausch is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Bausch Health Companies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bausch Health Companies and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Bausch. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bausch Health Companies has no effect on the direction of Pfizer i.e., Pfizer and Bausch go up and down completely randomly.

Pair Corralation between Pfizer and Bausch

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.85 times more return on investment than Bausch. However, Pfizer Inc is 1.18 times less risky than Bausch. It trades about 0.18 of its potential returns per unit of risk. Bausch Health Companies is currently generating about -0.01 per unit of risk. If you would invest  2,557  in Pfizer Inc on October 11, 2024 and sell it today you would earn a total of  129.00  from holding Pfizer Inc or generate 5.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy80.0%
ValuesDaily Returns

Pfizer Inc  vs.  Bausch Health Companies

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
Bausch Health Companies 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bausch Health Companies are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Bausch is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pfizer and Bausch Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Bausch

The main advantage of trading using opposite Pfizer and Bausch positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Bausch can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch will offset losses from the drop in Bausch's long position.
The idea behind Pfizer Inc and Bausch Health Companies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Fundamental Analysis
View fundamental data based on most recent published financial statements